MIMEDX (MDXG) General Counsel receives new stock and option awards

Rhea-AI Filing Summary

Hulse William Frank IV reported acquisition or exercise transactions in this Form 4 filing.

MIMEDX GROUP, INC. General Counsel and Chief Administrative Officer William Frank Hulse IV reported equity awards on Common Stock and Stock Options. These are classified as grants or awards rather than open‑market purchases or sales.

The filing shows an award of 74,987 shares of Common Stock at a price per share of $0.0000, bringing his directly held Common Stock to 488,536 shares. According to the footnotes, this represents restricted stock that vests fully on the third anniversary of the grant, subject to his continued employment under the Restricted Stock Unit Agreement.

He also received Stock Options covering 62,758 shares at a price per share of $0.0000, increasing his directly held options to 171,190. The options vest 25% on each anniversary of the grant date, conditioned on his continued employment as described in the Nonqualified Stock Option Agreement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hulse William Frank IV

(Last) (First) (Middle)

1775 WEST OAK COMMONS COURT NE

(Street)

MARIETTA GA 30062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel and CAO

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		A		74,987(1)	A	$0	488,536	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$5.1	03/04/2026		A		62,758		(2)	03/03/2033	Common Stock	62,758	$0	171,190	D

Explanation of Responses:

1. Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

2. The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement..

Remarks:

	/s/William F. Hulse	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MIMEDX (MDXG) executive William Frank Hulse IV report on this Form 4?

He reported equity awards of Common Stock and Stock Options as grants. The filing shows 74,987 shares of Common Stock and options on 62,758 shares, both at $0.0000 per share, reflecting compensation rather than market trading activity.

How many MIMEDX (MDXG) common shares does William Frank Hulse IV hold after the reported awards?

After the awards, he directly holds 488,536 shares of MIMEDX common stock. This total includes the newly granted 74,987 restricted shares, which vest over time, as detailed in the related Restricted Stock Unit Agreement included in the footnotes.

What are the terms of the restricted stock granted to William Frank Hulse IV at MIMEDX (MDXG)?

The restricted stock grant of 74,987 shares vests fully on the third anniversary of the grant. Vesting is conditioned on his continued employment, as specified in the company’s Restricted Stock Unit Agreement referenced in the Form 4 footnotes.

How do the stock options granted to William Frank Hulse IV at MIMEDX (MDXG) vest?

The 62,758 stock options vest in four equal installments of 25% each year. Vesting occurs on each anniversary of the grant date, provided he remains employed, under the Nonqualified Stock Option Agreement described in the Form 4 footnotes.

Are the MIMEDX (MDXG) equity transactions for William Frank Hulse IV open‑market buys or sells?

No, they are not open‑market buys or sells. The Form 4 classifies both the common stock and option entries with code “A,” indicating grants or awards of equity compensation rather than discretionary purchases or sales in the public market.

What total number of MIMEDX (MDXG) stock options does William Frank Hulse IV hold after this grant?

Following the reported grant, he directly holds stock options on 171,190 shares. This figure includes the newly awarded 62,758 options that vest annually in 25% increments, contingent on his continued employment with the company.